Collaboration with Intel® for medical screening optimizations powered by AI
Taipei,, March 31, 2025 / Prnewswire / – Acer Medical recently launched its AI assisted screening software, the diabetic retinopathy of the veritor and the macular degeneration linked to the age of the truth. These innovative solutions will be presented at the Annual Congress of Malaysia Ophthalmology Society (MSO), providing cutting AI screening technology Malaysia Ophthalmic community.
In collaboration with Intel, Acer Medical advances AI medical imagery by accelerating AI inference and optimization of resource use with Openvino ™ technology operating on Intel® Core ™ Ultra processors. Openvino ™ is an open source software toolbox designed to optimize and deploy in depth learning models. It considerably reduces development time by rationalizing the implementation of the code, facilitates rapid scalability and improves the effectiveness of AI solutions. This collaboration guarantees that advanced medical AI solutions can be deployed at all levels of medical institutions to treat retinal images of colors in real time, thus making the solution more accessible while improving the efficiency and precision of the diagnosis.
Rising Diabetes Prevalence and Aging Malaysia Lead the adoption of AI to ophthalmology
According to data from the Malaysian Medical Device Authority (MDA), Malaysia to one of the highest prevalence rates of diabetes in Southeast Asia. Diabetes affects 18.3% of adults aged 18 and over, which means that around one in five Malaysian is diagnosed with the disease. With an aging population, the incidence of diabetic complications, including diabetic retinopathy, is expected to increase.
In addition, Malaysia Transitioning in an aging society, the proportion of people aged 65 and over, providing for 15.3% * by 2040. Age -related macular degeneration has become a main cause of visual impairment among the elderly, stressing the urgent need for early detection and preventive ophthalmic care.
Acer Medical collaborates with hospitals and clinics Malaysia To assess AI medical solutions, improve diagnostic and efficiency accuracy. The Vérise ophthalmic screening software analyzes the background images in a few seconds, offering high -precision diabetic retinopathy detection and age -related macular degeneration. AI screening technology improves medical efficiency, allowing faster diagnostics in primary care establishments and guaranteeing timely treatment recommendations.
Intel® Openvino ™ improves the performance and accessibility of AI in a clinical environment
To guarantee the transparent operation of AI medical solutions in clinical environment, Acer Medical has teamed up with Intel to offer a trial program with the AI solutions of Vérisée series with openvino ™ technology deployed on laptops powered by Intel® Core ™ Ultra Processors. This collaboration is implemented in prominent hospitals such as the Universiti Malaysia Sabah Hospital (HUM) and the International Medical University (IMU) Hospital.
